Concepts (193)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Arrhythmias, Cardiac | 12 | 2021 | 2510 | 1.67 | Why? |
| Device Removal | 6 | 2018 | 221 | 1.45 | Why? |
| Defibrillators, Implantable | 6 | 2018 | 624 | 1.44 | Why? |
| Catheter Ablation | 10 | 2020 | 438 | 1.12 | Why? |
| Pacemaker, Artificial | 4 | 2019 | 431 | 0.92 | Why? |
| Cardiac Pacing, Artificial | 2 | 2020 | 160 | 0.90 | Why? |
| Electrodes, Implanted | 2 | 2018 | 60 | 0.89 | Why? |
| Femoral Vein | 1 | 2019 | 43 | 0.77 | Why? |
| Electrocardiography | 5 | 2020 | 3957 | 0.77 | Why? |
| Sternotomy | 1 | 2018 | 45 | 0.74 | Why? |
| Bradycardia | 1 | 2020 | 292 | 0.64 | Why? |
| Azithromycin | 3 | 2020 | 3943 | 0.64 | Why? |
| Prosthesis Implantation | 1 | 2019 | 261 | 0.64 | Why? |
| Warfarin | 1 | 2018 | 402 | 0.53 | Why? |
| Out-of-Hospital Cardiac Arrest | 2 | 2021 | 1047 | 0.51 | Why? |
| Drug Monitoring | 1 | 2020 | 1408 | 0.46 | Why? |
| Atrial Fibrillation | 7 | 2021 | 2320 | 0.45 | Why? |
| Heart-Assist Devices | 1 | 2018 | 812 | 0.40 | Why? |
| Tachycardia, Ventricular | 3 | 2018 | 251 | 0.39 | Why? |
| Endovascular Procedures | 1 | 2019 | 1302 | 0.38 | Why? |
| Electrophysiologic Techniques, Cardiac | 3 | 2021 | 396 | 0.36 | Why? |
| Inpatients | 3 | 2021 | 5161 | 0.35 | Why? |
| Hydroxychloroquine | 3 | 2020 | 12447 | 0.35 | Why? |
| Acute Coronary Syndrome | 1 | 2020 | 2107 | 0.32 | Why? |
| Thromboembolism | 1 | 2018 | 2101 | 0.29 | Why? |
| Heart Atria | 2 | 2018 | 267 | 0.29 | Why? |
| Chloroquine | 1 | 2020 | 3152 | 0.29 | Why? |
| Emergency Medical Services | 1 | 2020 | 3557 | 0.26 | Why? |
| Cardiac Electrophysiology | 2 | 2020 | 239 | 0.23 | Why? |
| Electrophysiology | 1 | 2020 | 64 | 0.21 | Why? |
| Anti-Arrhythmia Agents | 3 | 2018 | 325 | 0.21 | Why? |
| Telemedicine | 7 | 2021 | 25032 | 0.20 | Why? |
| Medical Device Recalls | 1 | 2018 | 5 | 0.19 | Why? |
| High-Frequency Ventilation | 1 | 2019 | 57 | 0.19 | Why? |
| Electrocardiography, Ambulatory | 1 | 2021 | 204 | 0.19 | Why? |
| Equipment Failure | 2 | 2011 | 197 | 0.19 | Why? |
| Software Design | 1 | 2018 | 87 | 0.18 | Why? |
| Pulmonary Veins | 1 | 2019 | 146 | 0.18 | Why? |
| Torsades de Pointes | 1 | 2020 | 229 | 0.18 | Why? |
| Aneurysm, False | 1 | 2019 | 88 | 0.17 | Why? |
| Operative Time | 1 | 2019 | 450 | 0.17 | Why? |
| Telemetry | 1 | 2020 | 240 | 0.17 | Why? |
| Balloon Occlusion | 1 | 2017 | 39 | 0.17 | Why? |
| Heart Conduction System | 1 | 2020 | 266 | 0.17 | Why? |
| Heart Failure | 1 | 2018 | 6638 | 0.16 | Why? |
| Prosthesis Failure | 1 | 2018 | 195 | 0.16 | Why? |
| Therapeutic Irrigation | 1 | 2017 | 167 | 0.16 | Why? |
| Vascular System Injuries | 1 | 2017 | 91 | 0.16 | Why? |
| Endpoint Determination | 1 | 2018 | 344 | 0.16 | Why? |
| Pneumonia, Viral | 10 | 2020 | 243684 | 0.16 | Why? |
| Medical History Taking | 1 | 2018 | 350 | 0.15 | Why? |
| Coronavirus Infections | 10 | 2020 | 253789 | 0.15 | Why? |
| Death, Sudden, Cardiac | 1 | 2021 | 522 | 0.15 | Why? |
| Subacute Care | 1 | 2020 | 315 | 0.15 | Why? |
| Risk Adjustment | 1 | 2020 | 730 | 0.15 | Why? |
| Government Agencies | 1 | 2017 | 248 | 0.15 | Why? |
| Atrial Flutter | 1 | 2017 | 143 | 0.15 | Why? |
| Postoperative Complications | 4 | 2018 | 5861 | 0.14 | Why? |
| Cryosurgery | 1 | 2015 | 57 | 0.14 | Why? |
| Stomach | 1 | 2015 | 141 | 0.14 | Why? |
| Prosthesis-Related Infections | 1 | 2018 | 302 | 0.14 | Why? |
| Computer Security | 1 | 2018 | 408 | 0.13 | Why? |
| Cardiology Service, Hospital | 1 | 2021 | 602 | 0.13 | Why? |
| Esophagus | 1 | 2015 | 139 | 0.13 | Why? |
| Intersectoral Collaboration | 1 | 2020 | 1065 | 0.12 | Why? |
| Pandemics | 12 | 2020 | 389249 | 0.12 | Why? |
| Pericardium | 1 | 2015 | 228 | 0.12 | Why? |
| New York City | 3 | 2021 | 7432 | 0.12 | Why? |
| Risk Factors | 12 | 2021 | 71621 | 0.12 | Why? |
| Follow-Up Studies | 3 | 2020 | 17020 | 0.12 | Why? |
| Disease Management | 2 | 2020 | 6841 | 0.11 | Why? |
| Cardiomyopathies | 2 | 2018 | 997 | 0.11 | Why? |
| Male | 23 | 2021 | 367725 | 0.10 | Why? |
| United States | 8 | 2020 | 46150 | 0.10 | Why? |
| Aged | 17 | 2021 | 215776 | 0.10 | Why? |
| Retrospective Studies | 10 | 2021 | 105322 | 0.10 | Why? |
| Myocardial Ischemia | 1 | 2016 | 781 | 0.10 | Why? |
| Ethanol | 1 | 2015 | 533 | 0.10 | Why? |
| Lasers | 1 | 2010 | 132 | 0.10 | Why? |
| Humans | 35 | 2021 | 930598 | 0.09 | Why? |
| Social Determinants of Health | 1 | 2021 | 1757 | 0.09 | Why? |
| Feasibility Studies | 1 | 2018 | 3467 | 0.09 | Why? |
| New York | 3 | 2020 | 2488 | 0.09 | Why? |
| Betacoronavirus | 8 | 2020 | 204454 | 0.09 | Why? |
| American Heart Association | 2 | 2020 | 347 | 0.09 | Why? |
| Treatment Outcome | 6 | 2020 | 51732 | 0.09 | Why? |
| Antimalarials | 1 | 2020 | 2505 | 0.09 | Why? |
| Action Potentials | 2 | 2020 | 368 | 0.08 | Why? |
| Female | 21 | 2021 | 380317 | 0.08 | Why? |
| Drug Therapy, Combination | 1 | 2020 | 7268 | 0.08 | Why? |
| Healthcare Disparities | 2 | 2021 | 3893 | 0.08 | Why? |
| Time Factors | 9 | 2021 | 31397 | 0.08 | Why? |
| Cardiovascular Diseases | 2 | 2021 | 11497 | 0.07 | Why? |
| Incidence | 4 | 2021 | 25622 | 0.07 | Why? |
| Remote Consultation | 1 | 2020 | 2396 | 0.07 | Why? |
| Cardiology | 1 | 2020 | 2873 | 0.07 | Why? |
| Middle Aged | 16 | 2021 | 270681 | 0.07 | Why? |
| Clinical Decision-Making | 1 | 2018 | 3755 | 0.07 | Why? |
| Risk Assessment | 7 | 2021 | 25439 | 0.07 | Why? |
| Delivery of Health Care | 2 | 2020 | 15909 | 0.07 | Why? |
| Comorbidity | 4 | 2020 | 34796 | 0.06 | Why? |
| Health Status Disparities | 1 | 2021 | 4072 | 0.06 | Why? |
| Hospitalization | 4 | 2021 | 54280 | 0.06 | Why? |
| Tertiary Care Centers | 1 | 2020 | 8248 | 0.06 | Why? |
| Disease-Free Survival | 2 | 2018 | 1654 | 0.06 | Why? |
| Elective Surgical Procedures | 1 | 2020 | 5338 | 0.06 | Why? |
| Prognosis | 3 | 2020 | 32490 | 0.06 | Why? |
| Research Design | 1 | 2018 | 5830 | 0.06 | Why? |
| Radiography, Thoracic | 1 | 2018 | 5486 | 0.06 | Why? |
| Infection Control | 2 | 2020 | 23131 | 0.05 | Why? |
| Treatment Failure | 2 | 2018 | 2106 | 0.05 | Why? |
| Hospital Mortality | 2 | 2021 | 22087 | 0.05 | Why? |
| Equipment Design | 1 | 2011 | 3095 | 0.05 | Why? |
| Patient Safety | 3 | 2020 | 4885 | 0.05 | Why? |
| Heart Rate | 2 | 2020 | 1527 | 0.05 | Why? |
| Epicardial Mapping | 1 | 2018 | 12 | 0.05 | Why? |
| Practice Guidelines as Topic | 2 | 2020 | 15421 | 0.05 | Why? |
| Electrodes | 1 | 2019 | 203 | 0.05 | Why? |
| Antiviral Agents | 3 | 2021 | 41703 | 0.05 | Why? |
| Surgical Instruments | 1 | 2019 | 145 | 0.05 | Why? |
| Clinical Trials as Topic | 1 | 2018 | 7330 | 0.05 | Why? |
| Aged, 80 and over | 5 | 2021 | 88759 | 0.05 | Why? |
| Registries | 1 | 2018 | 12327 | 0.04 | Why? |
| Biophysical Phenomena | 1 | 2017 | 78 | 0.04 | Why? |
| Device Approval | 1 | 2018 | 93 | 0.04 | Why? |
| Anti-Bacterial Agents | 1 | 2020 | 10083 | 0.04 | Why? |
| Vena Cava, Superior | 1 | 2017 | 30 | 0.04 | Why? |
| Intraoperative Care | 1 | 2019 | 238 | 0.04 | Why? |
| Prospective Studies | 2 | 2020 | 43301 | 0.04 | Why? |
| Cardiotoxicity | 1 | 2020 | 365 | 0.04 | Why? |
| Cardiac Imaging Techniques | 1 | 2020 | 357 | 0.04 | Why? |
| Anticoagulants | 1 | 2018 | 9563 | 0.04 | Why? |
| International Cooperation | 2 | 2021 | 3436 | 0.04 | Why? |
| Tidal Volume | 1 | 2019 | 565 | 0.04 | Why? |
| Global Health | 1 | 2020 | 13911 | 0.04 | Why? |
| Radiography, Interventional | 1 | 2018 | 158 | 0.04 | Why? |
| Esophageal Perforation | 1 | 2015 | 11 | 0.04 | Why? |
| Population Density | 1 | 2021 | 694 | 0.04 | Why? |
| Cicatrix | 1 | 2016 | 129 | 0.04 | Why? |
| Patient Selection | 2 | 2020 | 4560 | 0.04 | Why? |
| Emergency Service, Hospital | 1 | 2020 | 14232 | 0.04 | Why? |
| Esophageal Diseases | 1 | 2015 | 34 | 0.04 | Why? |
| Organizational Policy | 1 | 2020 | 694 | 0.04 | Why? |
| Florida | 1 | 2017 | 598 | 0.04 | Why? |
| Educational Status | 1 | 2021 | 1451 | 0.03 | Why? |
| Societies, Medical | 2 | 2021 | 6907 | 0.03 | Why? |
| Ulcer | 1 | 2015 | 128 | 0.03 | Why? |
| Communicable Disease Control | 2 | 2020 | 29620 | 0.03 | Why? |
| Return to Work | 1 | 2020 | 579 | 0.03 | Why? |
| Boston | 1 | 2016 | 929 | 0.03 | Why? |
| Causality | 1 | 2017 | 857 | 0.03 | Why? |
| Adult | 6 | 2021 | 244371 | 0.03 | Why? |
| Reoperation | 1 | 2015 | 544 | 0.03 | Why? |
| Propensity Score | 1 | 2021 | 2690 | 0.03 | Why? |
| Program Evaluation | 1 | 2020 | 1929 | 0.03 | Why? |
| United States Food and Drug Administration | 1 | 2018 | 1276 | 0.03 | Why? |
| Organizational Innovation | 1 | 2021 | 2468 | 0.03 | Why? |
| Residence Characteristics | 1 | 2021 | 1927 | 0.03 | Why? |
| Medicare | 1 | 2017 | 1048 | 0.03 | Why? |
| Monitoring, Physiologic | 1 | 2020 | 1956 | 0.02 | Why? |
| Poverty | 1 | 2021 | 2302 | 0.02 | Why? |
| Swine | 1 | 2017 | 3352 | 0.02 | Why? |
| Vascular Surgical Procedures | 1 | 2017 | 882 | 0.02 | Why? |
| Long-Term Care | 1 | 2020 | 2047 | 0.02 | Why? |
| Recurrence | 1 | 2018 | 3675 | 0.02 | Why? |
| Ventricular Function, Left | 1 | 2016 | 1555 | 0.02 | Why? |
| Congresses as Topic | 1 | 2017 | 1347 | 0.02 | Why? |
| Outpatients | 1 | 2020 | 3417 | 0.02 | Why? |
| Survival Analysis | 1 | 2020 | 7592 | 0.02 | Why? |
| Stroke Volume | 1 | 2016 | 2153 | 0.02 | Why? |
| Cause of Death | 1 | 2020 | 4823 | 0.02 | Why? |
| Heart Transplantation | 1 | 2016 | 1293 | 0.02 | Why? |
| Forecasting | 1 | 2021 | 4492 | 0.02 | Why? |
| African Americans | 1 | 2021 | 3363 | 0.02 | Why? |
| Proportional Hazards Models | 1 | 2016 | 6543 | 0.02 | Why? |
| Health Surveys | 1 | 2015 | 2841 | 0.02 | Why? |
| Consensus | 1 | 2018 | 6345 | 0.02 | Why? |
| Clinical Laboratory Techniques | 2 | 2020 | 23402 | 0.02 | Why? |
| Ambulatory Care | 1 | 2020 | 4947 | 0.02 | Why? |
| Databases, Factual | 1 | 2018 | 6248 | 0.02 | Why? |
| Survival Rate | 1 | 2017 | 9206 | 0.02 | Why? |
| Case-Control Studies | 1 | 2019 | 17671 | 0.01 | Why? |
| Mass Screening | 1 | 2020 | 8005 | 0.01 | Why? |
| Reproducibility of Results | 1 | 2017 | 11304 | 0.01 | Why? |
| Young Adult | 2 | 2021 | 93724 | 0.01 | Why? |
| Disease Progression | 1 | 2016 | 13580 | 0.01 | Why? |
| Age Factors | 1 | 2017 | 21039 | 0.01 | Why? |
| Sensitivity and Specificity | 1 | 2017 | 22971 | 0.01 | Why? |
| Personal Protective Equipment | 1 | 2020 | 15978 | 0.01 | Why? |
| Respiration, Artificial | 1 | 2019 | 22116 | 0.01 | Why? |
| Adolescent | 1 | 2020 | 86841 | 0.01 | Why? |
| Health Personnel | 1 | 2020 | 29646 | 0.01 | Why? |
| Animals | 1 | 2017 | 78931 | 0.01 | Why? |
Epstein's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(193)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(111)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_